Clinical Trial Update: Valproic Acid in Combination With Bevacizumab and Oxaliplatin/Fluoropyrimidine Regimens in Patients With Ras-mutated Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating valproic acid with bevacizumab and oxaliplatin/fluoropyrimidine in Ras-mutated metastatic colorectal cancer is ongoing with status curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ras-mutated Metastatic Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• OXALIPLATIN (Oxaliplatin)
• VALPROIC ACID (Valproic acid)
• fluoropyrimidine (fluoropyrimidine)

Snippet

Sponsor: National Cancer Institute, Naples | Conditions: Ras-mutated Metastatic Colorectal Cancer | Phase 2 | Status: UNKNOWN